Zepp Health Corp 6-K, filed Aug 4, 2025

Zepp Health Corp (ZEPP)

6-K 2025-08-04 For: 2025-08-04

Added on April 06, 2026

About this 6-K

Zepp Health Corp filed this 6-K on August 4, 2025.

	As of December 31,	As of June 30,
	2024	2025
	US$	US$
Assets
Current assets:
Cash and cash equivalents	91,069	55,445
Restricted cash	19,666	39,875
Accounts receivable, net	62,965	70,916
Amounts due from related parties	2,663	3,661
Inventories, net	56,789	79,911
Short-term investments	997	1,015
Prepaid expenses and other current assets	17,415	21,615
Total current assets	251,564	272,438

Property, plant and equipment, net	6,898	6,161
Intangible asset, net	7,091	14,352
Goodwill	9,581	9,581
Long-term investments	225,910	218,970
Deferred tax assets	17,465	17,666
Amount due from related parties, non-current	2,019	2,051
Other non-current assets	4,607	4,693
Operating lease right-of-use assets	3,458	3,059
Total assets	528,593	548,971

	As of December 31,		As of June 30,
	2024		2025
	US$		US$
Liabilities
Current liabilities:
Accounts payable		51,077		86,517
Advance from customers		197		250
Amount due to related parties		2,477		531
Accrued expenses and other current liabilities		37,576		38,847
Income tax payables		508		508
Notes payable		61,679		86,623
Short-term bank borrowings		41,853		35,038
Total current liabilities		195,367		248,314
Deferred tax liabilities		3,117		3,143
Long-term borrowings		75,241		70,403
Other non-current liabilities		133		136
Non-current operating lease liabilities		2,007		1,585
Total liabilities		275,865		323,581

	For the Three Months Ended June 30,
	2024			2025
	US$			US$
Revenues		40,642			59,406
Cost of revenues		(24,281	)		(37,915	)
Gross profit		16,361			21,491
Operating expenses:
Selling and marketing		(10,555	)		(12,050	)
General and administrative		(4,853	)		(4,384	)
Research and development		(10,818	)		(11,157	)
Total operating expenses		(26,226	)		(27,591	)
Operating loss		(9,865	)		(6,100	)

Other income and expenses:
Interest income		948			295
Interest expense		(1,373	)		(1,245	)
Other income/(expense), net		127			56
Gain/(loss) from fair value change of long-term investments		(300	)		3
Loss before income tax and loss from equity method investments		(10,463	)		(6,991	)
Income tax expenses		(47	)		(242	)
Loss before loss from equity method investments		(10,510	)		(7,233	)
Net loss from equity method investments		(337	)		(507	)
Net loss		(10,847	)		(7,740	)
Less: Net loss attributable to noncontrolling interest		(10	)		-
Net loss attributable to Zepp Health Corporation		(10,837	)		(7,740	)

Basic and diluted net loss per share attributable to Zepp Health Corporation		(0.04	)		(0.03	)

Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS)		(0.67	)		(0.49	)

Weighted average number of shares used in computing basic and diluted net loss per share		260,399,926			253,536,783

	For the Six Months Ended June 30,
	2024			2025
	US$			US$
Revenues		80,599			97,943
Cost of revenues		(49,538	)		(62,091	)
Gross profit		31,061			35,852
Operating expenses:
Selling and marketing		(21,324	)		(25,891	)
General and administrative		(11,273	)		(10,902	)
Research and development		(24,239	)		(23,534	)
Total operating expenses		(56,836	)		(60,327	)
Operating loss		(25,775	)		(24,475	)

Other income and expenses:
Interest income		1,960			876
Interest expense		(2,816	)		(2,603	)
Other income/(expense), net		195			60
Gain/(loss) from fair value change of long-term investments		1,803			(122	)
Loss before income tax and loss from equity method investments		(24,633	)		(26,264	)
Income tax expenses		(119	)		(352	)
Loss before loss from equity method investments		(24,752	)		(26,616	)
Net loss from equity method investments		(896	)		(865	)
Net loss		(25,648	)		(27,481	)
Less: Net loss attributable to noncontrolling interest		(42	)		-
Net loss attributable to Zepp Health Corporation		(25,606	)		(27,481	)

Basic and diluted net loss per share attributable to Zepp Health Corporation		(0.10	)		(0.11	)

Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS)		(1.58	)		(1.72	)

Weighted average number of shares used in computing basic and diluted net loss per share		259,962,803			254,965,539

	As of December 31,			As of June 30,
	2024			2025
	US$			US$
Equity
Ordinary shares		26			26
Additional paid-in capital		278,116			279,258
Treasury stock		(14,993	)		(16,045	)
Accumulated retained earnings		28,618			1,137
Accumulated other comprehensive loss		(40,178	)		(38,986	)
Total Zepp Health Corporation shareholders’ equity		251,589			225,390
Noncontrolling interest		1,139			-
Total equity		252,728			225,390
Total liabilities and equity		528,593			548,971